-5%
Empagliflozin is a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor, which works by blocking glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. This helps lower blood sugar levels.
Metformin Hydrochloride is a biguanide-class oral antidiabetic drug that lowers blood glucose levels without causing hypoglycemia. It functions by:
- Reducing liver glucose production
- Decreasing glucose absorption in the intestines
- Enhancing insulin sensitivity to promote better glucose uptake by cells.
Empatab M ER is prescribed for adults with Type 2 diabetes mellitus as a supplementary treatment to diet and exercise. It is used in the following scenarios:
- When Metformin alone (at its maximum tolerated dose) does not adequately control blood sugar levels.
- In combination with other diabetes medications for patients who are not achieving optimal glycemic control with Metformin and those medications.
- For patients already taking Empagliflozin and Metformin as separate tablets, transitioning to this combination simplifies the treatment regimen.